| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 8375F9S90C |
| InChI Key | DENYZIUJOTUUNY-MRXNPFEDSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H15FN4O |
| Molecular Weight | 298.32 |
| AlogP | 2.08 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 0.0 |
| Polar Surface Area | 60.49 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 22.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Transferase
|
0-13 | 1 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | - | - | - | 51 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | 19400 | - | - | - | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC22 family of organic cation and anion transporters
|
- | 23900 | - | - | - | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCG subfamily
|
- | - | - | - | 43 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Ovarian Neoplasms | 3 | D010051 | ClinicalTrials |
| Neoplasms | 3 | D009369 | ClinicalTrials |
| Neoplasms | 3 | D009369 | ClinicalTrials |
| Biliary Tract Neoplasms | 2 | D001661 | ClinicalTrials |
| Stomach Neoplasms | 2 | D013274 | ClinicalTrials |
| Breast Neoplasms | 2 | D001943 | ClinicalTrials |
| Prostatic Neoplasms, Castration-Resistant | 2 | D064129 | ClinicalTrials |
| Glioblastoma | 1 | D005909 | ClinicalTrials |
| Central Nervous System Neoplasms | 1 | D016543 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4112930 |
| DrugBank | DB14769 |
| FDA SRS | 8375F9S90C |
| PDB | DS9 |
| SureChEMBL | SCHEMBL15084918 |
| ZINC | ZINC000150196116 |